DE3138094A1 - Mittel zur verbesserung der blutzirkulation - Google Patents

Mittel zur verbesserung der blutzirkulation

Info

Publication number
DE3138094A1
DE3138094A1 DE19813138094 DE3138094A DE3138094A1 DE 3138094 A1 DE3138094 A1 DE 3138094A1 DE 19813138094 DE19813138094 DE 19813138094 DE 3138094 A DE3138094 A DE 3138094A DE 3138094 A1 DE3138094 A1 DE 3138094A1
Authority
DE
Germany
Prior art keywords
blood
erythrocytes
gelatin
collagen
hemolysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19813138094
Other languages
German (de)
English (en)
Inventor
Hiroshi Maeda
Katsuhide Kumamoto Nishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maeda Hiroshi Nishi Katsuhide Kumamoto Jp
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of DE3138094A1 publication Critical patent/DE3138094A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19813138094 1980-09-25 1981-09-24 Mittel zur verbesserung der blutzirkulation Withdrawn DE3138094A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55132336A JPS5767521A (en) 1980-09-25 1980-09-25 Agent for improving circulation blood vessel

Publications (1)

Publication Number Publication Date
DE3138094A1 true DE3138094A1 (de) 1982-05-06

Family

ID=15078940

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813138094 Withdrawn DE3138094A1 (de) 1980-09-25 1981-09-24 Mittel zur verbesserung der blutzirkulation

Country Status (8)

Country Link
US (1) US4446136A (cg-RX-API-DMAC7.html)
JP (1) JPS5767521A (cg-RX-API-DMAC7.html)
CA (1) CA1188222A (cg-RX-API-DMAC7.html)
CH (1) CH649221A5 (cg-RX-API-DMAC7.html)
DE (1) DE3138094A1 (cg-RX-API-DMAC7.html)
FR (1) FR2490494A1 (cg-RX-API-DMAC7.html)
GB (1) GB2086724B (cg-RX-API-DMAC7.html)
IT (1) IT1195970B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735460A1 (de) * 1997-08-16 1999-02-18 Rolf Prof Dr Med Zander Spül- oder Lagerungsflüssigkeit für Blutzellen

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
IL104670A (en) * 1993-02-09 1998-04-05 Travenol Lab Israel Ltd Leukocyte removal method and filter unit for same

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591133A (en) * 1950-05-29 1952-04-01 California Inst Res Found Method of producing gelatin derivative
GB886553A (en) * 1958-01-22 1962-01-10 Hoechst Ag Substitutes for blood plasma and process for their manufacture
DE1276650B (de) * 1962-05-11 1968-09-05 Iabiotestia Serum Inst G M B H Verfahren zur Herstellung von als Blutplasmaersatzmittel geeigneten, modifizierten Proteinzubereitungen
GB1227534A (cg-RX-API-DMAC7.html) * 1967-08-31 1971-04-07
GB1313164A (en) * 1969-04-28 1973-04-11 Knox Gelatine Inc Blood plasma substitute
DE2348294A1 (de) * 1973-09-26 1975-04-03 Hausmann Ag Labor Modifizierte gelatine mit erniedrigtem gelschmelzpunkt

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3057782A (en) * 1958-01-22 1962-10-09 Hoechst Ag Cross-linked gelatin plasma substitute and production thereof
US3035982A (en) * 1958-12-05 1962-05-22 Merck & Co Inc Repository vitamin b12 gelatin compositions and preparation thereof
US3163543A (en) * 1962-06-19 1964-12-29 J O Whitten Company Inc Process of producing gelatin products
CH441621A (de) * 1963-06-04 1967-08-15 Bayer Ag Verfahren zur Herstellung von als Blutersatzflüssigkeit verwendbaren Gelatinepräparaten
FR1529055A (fr) * 1966-06-18 1968-06-14 Bayer Ag Procédé pour fabriquer des solutions de gélatine sans agents pyrogènes utilisables comme préparations remplaçant le sang
US3794729A (en) * 1971-07-16 1974-02-26 Schering Corp Inhibiting blood platelet aggregation
US4178361A (en) * 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
DE2462222A1 (de) * 1974-02-02 1976-05-06 Trommsdorff Fa H Loesliches, natives human-kollagen, dessen nicht-helikale peptide teilweise oder vollstaendig abgetrennt sind
DE2405002B2 (de) * 1974-02-02 1979-07-19 Fa. H. Trommsdorff, 5110 Alsdorf Lösliches natives Kollagen aus menschlicher Plancenta sowie dieses als therapeutischen Wirkstoff enthaltendes Mittel
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4002739A (en) * 1975-02-18 1977-01-11 Warner-Lambert Company Soluble collagen
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
DE2657370C2 (de) * 1976-12-17 1982-11-11 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Mittel zum Bedecken und/oder Ausfüllen von Knochendefekten
US4164559A (en) * 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
US4224328A (en) * 1979-04-11 1980-09-23 Sandoz, Inc. Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors
JPS5615213A (en) * 1979-07-13 1981-02-14 Hiroshi Maeda Ameliorant of peripheral circulatory insufficiency

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591133A (en) * 1950-05-29 1952-04-01 California Inst Res Found Method of producing gelatin derivative
GB886553A (en) * 1958-01-22 1962-01-10 Hoechst Ag Substitutes for blood plasma and process for their manufacture
DE1276650B (de) * 1962-05-11 1968-09-05 Iabiotestia Serum Inst G M B H Verfahren zur Herstellung von als Blutplasmaersatzmittel geeigneten, modifizierten Proteinzubereitungen
GB1227534A (cg-RX-API-DMAC7.html) * 1967-08-31 1971-04-07
GB1313164A (en) * 1969-04-28 1973-04-11 Knox Gelatine Inc Blood plasma substitute
DE2348294A1 (de) * 1973-09-26 1975-04-03 Hausmann Ag Labor Modifizierte gelatine mit erniedrigtem gelschmelzpunkt

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DE-B: Rote Liste 1980, Editio Cantor, Aulen- dorf/Württ., Nr. 51293 B Gelifundol, Nr. 21294 B Gelifundol S, Nr. 51295 B Haemaccel, Nr. 51296 B neo-Plasmagel, Nr. 51297 B Physiogel *
FR 4072M-M *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735460A1 (de) * 1997-08-16 1999-02-18 Rolf Prof Dr Med Zander Spül- oder Lagerungsflüssigkeit für Blutzellen
US6194138B1 (en) 1997-08-16 2001-02-27 Rolf Zander Method for flushing blood cells using gelatin

Also Published As

Publication number Publication date
JPS5767521A (en) 1982-04-24
US4446136A (en) 1984-05-01
IT8168240A0 (it) 1981-09-24
GB2086724B (en) 1985-07-17
IT1195970B (it) 1988-11-03
JPS619287B2 (cg-RX-API-DMAC7.html) 1986-03-22
GB2086724A (en) 1982-05-19
CA1188222A (en) 1985-06-04
FR2490494A1 (fr) 1982-03-26
CH649221A5 (de) 1985-05-15
FR2490494B1 (cg-RX-API-DMAC7.html) 1984-12-21

Similar Documents

Publication Publication Date Title
DE69029388T2 (de) Histidin gepufferte peritonealdialyselösung
DE69429169T2 (de) Pharmazeutisches präparat, das heparin, heparinfragmente oder -derivate in kombination mit glycerinestern enthält
DE69929550T2 (de) Albumin enthaltende Lösung für die Peritonealdialyse
EP0233279B1 (de) Neuartige verwendung von taurolin
DE2616086C2 (de) Substanz zur Verwendung in einem kolloidalen Blutvolumenersatzmittel aus Hydroxyethylstärke und Hämoglobin
DE3150318C2 (de) "Verfahren zur Herstellung eines Polysaccharidderivats des Fibrinolysins"
DE3877154T2 (de) Verfahren zur verhinderung der bildung von blutgerinnseln in dem extrakorporalen kreislauf eines dialyseapparats sowie dazu geeignetes mittel.
DE2326600C2 (cg-RX-API-DMAC7.html)
EP1485120B1 (de) Verwendung eines oder mehrerer von plasma und zellwandbestandteilen befreiten natürlichen oder modifizierten sauerstoffbinder zur externen behandlung offener, insbesondere chronischer wunden
DE2734849A1 (de) Intravenoeses kreislaufmittel
EP0370994B1 (de) Behandlung von durch Glucose ausgelöster Quervernetzung von Collagen bei Diabetes mellitus-Patienten durch Arginin, Spermidin, Kreatin oder Agmatin
DE2919127C2 (de) Mittel zur Verringerung des Phenylalaningehalts
DE1767285C3 (de) Verfahren zur Herstellung eines stabilen, hochwirksamen AHF-Konzentrates und Mittel zur Behandlung der Hämophilie
DE69109676T2 (de) Verminderung von kardiovaskulären gefässverschlüssen mit ascorbat und hemmstoffen der bindung von lipoprotein (a).
DE3138094A1 (de) Mittel zur verbesserung der blutzirkulation
WO1992019245A1 (de) Verwendung von torasemid zur behandlung von hirnödemen
DE1902865A1 (de) Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
DE3843241A1 (de) Nephroprotektive infusionsloesung
DE2409650C3 (de) Verwendung wäßriger Lösung von menschlichem Serum-Haptoglobin bei der Bekämpfung von hämolytischen Nierenstörungen
DE2729903A1 (de) Antithrombosemittel
DE2246969C2 (de) Urokinase-Heparinat und dieses enthaltende Arzneimittel
DE3705669A1 (de) Verwendung von dextransulfat zur herstellung eines arzneimittels zur behandlung und prophylaxe von gefaessverengungen und gefaessverschluessen
US4362718A (en) Agent for curing peripheral circulation insufficiency
EP1682167B1 (de) Verwendung hyperpolymerer hämoglobine zur behandlung eines lungenödems
AT405241B (de) Verwendung von humanem alpha1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: MAEDA, HIROSHI NISHI, KATSUHIDE, KUMAMOTO, JP

8128 New person/name/address of the agent

Representative=s name: WUESTHOFF, F., DR.-ING. FRHR. VON PECHMANN, E., DI

8139 Disposal/non-payment of the annual fee